GUARDANT HEALTH, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- GUARDANT HEALTH, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $18.99M, a 1119.72% increase year-over-year.
- GUARDANT HEALTH, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $3.65M, a 375.39% increase year-over-year.
- GUARDANT HEALTH, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $13.18M, a 2424.33% increase year-over-year.
- GUARDANT HEALTH, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $3.72M, a 18505.00% increase year-over-year.
- GUARDANT HEALTH, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $19.22M, a 516.32% increase from fiscal 2024.
- GUARDANT HEALTH, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $3.12M, a 670.12% increase from fiscal 2023.
- GUARDANT HEALTH, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $405.00K, a 84.57% decline from fiscal 2022.
- GUARDANT HEALTH, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $2.63M, a 67.64% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $18.99M 10-Q · filed 2026-07-30 | $39.54M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $3.65M 10-Q · filed 2026-05-07 | $22.11M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $13.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $19.22M 10-K · filed 2026-02-19 |
| 2025-09-30 | $3.72M 10-Q · filed 2025-10-29 | $6.57M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $1.56M 10-Q · filed 2026-07-30 | $2.87M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $768.00K 10-Q · filed 2026-05-07 | $3.67M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $522.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $3.12M 10-K · filed 2026-02-19 |
| 2024-09-30 | $20.00K 10-Q · filed 2025-10-29 | $2.71M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $2.36M 10-Q · filed 2025-07-30 | $2.76M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $213.00K 10-Q · filed 2025-04-30 | $461.00K derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $405.00K 10-K · filed 2026-02-19 |
| 2023-09-30 | $70.00K 10-Q · filed 2024-11-06 | $411.00K derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $63.00K 10-Q · filed 2024-08-07 | $688.00K derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $157.00K 10-Q · filed 2024-05-09 | $1.82M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $2.63M 10-K · filed 2025-02-20 |
| 2022-09-30 | $347.00K 10-Q · filed 2023-11-06 | $3.55M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $1.19M 10-Q · filed 2023-08-03 | $4.88M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $963.00K 10-Q · filed 2023-05-09 | $4.61M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $8.11M 10-K · filed 2024-02-22 |
| 2021-09-30 | $1.68M 10-Q · filed 2022-11-03 | $9.19M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $926.00K 10-Q · filed 2022-08-04 | $11.37M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $4.46M 10-Q · filed 2022-05-05 | $12.49M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $9.53M 10-K · filed 2023-02-23 |
| 2020-09-30 | $3.85M 10-Q · filed 2021-11-04 | $9.24M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $2.04M 10-Q · filed 2021-08-05 | $9.66M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $1.50M 10-Q · filed 2021-05-06 | $12.60M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $11.64M 10-K · filed 2022-02-24 |
| 2019-09-30 | $4.26M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $4.99M 10-Q · filed 2020-08-06 | |
| 2019-03-31 | $538.00K 10-Q · filed 2020-05-07 | |
| 2018-12-31 | $2.90M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $839.00K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $424.00K 10-Q · filed 2019-11-07 | |
| 2018-03-31 | $1.10M 10-Q · filed 2019-11-07 | |
| 2017-12-31 | $753.00K 10-K · filed 2020-03-02 | |
| 2016-12-31 | $266.00K 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |